What question did this study set out to answer?

Compare the diagnostic accuracy of two MALDI-TOF MS platforms, VITEK-MS and Microflex LT, in identifying clinical bacterial blood culture isolates that could not be resolved by standard methods.

January 1, 2020FUKUSHIMA JOURNAL OF MEDICAL SCIENCEOpen Access

Validation of MALDI-TOF MS devices in reanalysis of unidentified pathogenic bacteria detected in blood cultures

View Full Paper

Ask AI

Bookmark

Authors

MIMinako ImaiFukushima Medical University Hospital YKYukio KimuraFukushima Medical University DTDaiki TannoShowa University

Discussion

Member takes

Implication

Comparative evaluation reveals higher species-level accuracy with Microflex LT than VITEK-MS in unresolved blood isolates, highlighting performance differences between platforms.

Key Points

Compare the diagnostic accuracy of two MALDI-TOF MS platforms, VITEK-MS and Microflex LT, in identifying clinical bacterial blood culture isolates that could not be resolved by standard methods.
Reanalyzed N=100 clinical bacterial strains isolated from blood cultures that were incompletely identified using standard morphological and biochemical techniques.
Tested all isolates in parallel using the VITEK-MS (BioMérieux) and Microflex LT (Bruker Daltonics) systems to assess species- and genus-level identification rates and device concordance.
Microflex LT identified 80% (80/100) of strains at the species level compared to 49% (49/100) by VITEK-MS, whereas genus-level rates were 95% (95/100) and 96% (96/100), respectively.
Device concordance was 26% (26/100) at the species level and 88% (88/100) at the genus level, with three discordant strains and failure to identify four strains on VITEK-MS versus five on Microflex LT.

Cite This Study

Imai et al. (2020) studied this question.

synapsesocial.com/papers/6a71ae75ac440176ef2a494e https://doi.org/10.5387/fms.2020-09

View Full Paper

Ask AI

Bookmark

Implication

Comparative evaluation reveals higher species-level accuracy with Microflex LT than VITEK-MS in unresolved blood isolates, highlighting performance differences between platforms.

Validation of MALDI-TOF MS devices in reanalysis of unidentified pathogenic bacteria detected in blood cultures

Discussion

Member takes

Implication

Key Points

Cite This Study

Validation of MALDI-TOF MS devices in reanalysis of unidentified pathogenic bacteria detected in blood cultures

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider